Clinical Trials Directory

Trials / Completed

CompletedNCT01421654

Evaluation of Acclimate Feature for Positive Airway Pressure (PAP) Therapy

Evaluation of Positive Airway Pressure (PAP) Feature to Improve Patient Adherence to Therapy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
ResMed · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate if using the Acclimate feature at the beginning of Positive Airway Pressure (PAP) therapy results in patients using their PAP therapy at least as long as they would standard therapy. Additionally, the Acclimate feature will be evaluated with regard to patient comfort, ease of acceptance of PAP therapy, leak events, and respiratory events.

Detailed description

Acclimate has been designed as a comfort feature for patients starting PAP therapy. The feature allows acclimatization to the targeted positive airway pressure setting. Using the Acclimate feature, the pressure increases incrementally over a period of time. The feature can be only be used for a set period of time, afterwards which the device initiates the therapeutic session at the prescribed pressure.

Conditions

Interventions

TypeNameDescription
DEVICES9 Elite with AcclimateS9 Elite Flow Generator with Acclimate feature activated
DEVICES9 EliteS9 Elite Flow Generator

Timeline

Start date
2011-09-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-08-23
Last updated
2013-03-12
Results posted
2013-03-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01421654. Inclusion in this directory is not an endorsement.

Evaluation of Acclimate Feature for Positive Airway Pressure (PAP) Therapy (NCT01421654) · Clinical Trials Directory